株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

精密医療(診断/治療)市場分析レポート:用途別(遺伝子検査、難解な検査、医薬品、医療機器)、エンドユース別、セグメント予測(2018〜2025年)

Precision Medicine (Diagnostics/Therapeutics) Market Analysis Report By Application (Genetic Tests, Esoteric Tests, Pharmaceuticals, Medical Devices), By End Use, And Segment Forecasts, 2018 - 2025

発行 Grand View Research, Inc. 商品コード 744637
出版日 ページ情報 英文 145 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.55円で換算しております。
Back to Top
精密医療(診断/治療)市場分析レポート:用途別(遺伝子検査、難解な検査、医薬品、医療機器)、エンドユース別、セグメント予測(2018〜2025年) Precision Medicine (Diagnostics/Therapeutics) Market Analysis Report By Application (Genetic Tests, Esoteric Tests, Pharmaceuticals, Medical Devices), By End Use, And Segment Forecasts, 2018 - 2025
出版日: 2018年10月17日 ページ情報: 英文 145 Pages
概要

世界の精密医療(診断/治療)市場は、今後CAGR9.9%で拡大し、2025年までに855億米ドルに達すると予測されています。費用対効果の高いゲノミクス、分子生物学検査の導入や、癌や奇病の罹患率上昇、精密医療におけるビッグデータの使用拡大などが市場の成長を牽引する要因となっています。

当レポートでは、世界の精密医療(診断/治療)市場について調査し、市場の動向と2025年までの予測、セグメント別動向、地域別動向、参入企業のプロファイルなどをまとめています。

第1章 調査方法

第2章 エグゼクティブサマリー

第3章 市場変数、動向、範囲

  • 市場セグメンテーションと範囲
    • 市場促進因子分析
    • 市場阻害因子分析
  • SWOT分析
  • 業界分析

第4章 市場分類:用途別

  • 動向分析
  • 診断
  • 治療
  • 医療機器
  • その他

第5章 市場分類:エンドユース別

  • 動向分析
  • 在宅ケア
  • 病院
  • 臨床試験所
  • その他

第6章 地域別予測と動向分析

  • 市場シェア
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第7章 競合環境

  • 戦略枠組み
  • 市場参入分類
  • 企業プロファイル
    • F. Hoffmann-La Roche Ltd.-Foundation Medicin
    • Siemens Healthineers
    • Janssen Pharmaceuticals
    • Illumina
    • Quest Diagnostics Incorporated.
    • 23andMe, Inc.
    • NeoDiagnostix, Inc.,
    • IBM Watson
    • Myriad Genetics Inc.
    • Medtronic
    • GE Healthcare
    • Abbott Laboratories
    • Dako A/S
    • Biogen
    • Precision Biologics Incorporated
    • Qiagen Incorporated
図表

List of Tables

  • TABLE 1 North America diagnostic and therapeutic precision medicine market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 2 North America diagnostic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 3 North America therapeutic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 4 North America precision medicine pharmaceuticals market estimates & forecasts, by indication area, 2014 - 2025 (USD Billion)
  • TABLE 5 North America diagnostic and therapeutic precision medicine market estimates & forecasts, by end use, 2014 - 2025 (USD Billion)
  • TABLE 6 U.S. diagnostic and therapeutic precision medicine market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 7 U.S. diagnostic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 8 U.S. therapeutic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 9 U.S. precision medicine pharmaceuticals market estimates & forecasts, by indication area, 2014 - 2025 (USD Billion)
  • TABLE 10 U.S. diagnostic and therapeutic precision medicine market estimates & forecasts, by end use, 2014 - 2025 (USD Billion)
  • TABLE 11 Canada diagnostic and therapeutic precision medicine market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 12 Canada diagnostic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 13 Canada therapeutic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 14 Canada precision medicine pharmaceuticals market estimates & forecasts, by indication area, 2014 - 2025 (USD Billion)
  • TABLE 15 Canada diagnostic and therapeutic precision medicine market estimates & forecasts, by end use, 2014 - 2025 (USD Billion)
  • TABLE 16 Europe diagnostic and therapeutic precision medicine market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 17 Europe diagnostic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 18 Europe therapeutic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 19 Europe precision medicine pharmaceuticals market estimates & forecasts, by indication area, 2014 - 2025 (USD Billion)
  • TABLE 20 Europe diagnostic and therapeutic precision medicine market estimates & forecasts, by end use, 2014 - 2025 (USD Billion)
  • TABLE 21 U.K. diagnostic and therapeutic precision medicine market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 22 U.K. diagnostic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 23 U.K. therapeutic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 24 U.K. precision medicine pharmaceuticals market estimates & forecasts, by indication area, 2014 - 2025 (USD Billion)
  • TABLE 25 U.K. diagnostic and therapeutic precision medicine market estimates & forecasts, by end use, 2014 - 2025 (USD Billion)
  • TABLE 26 Germany diagnostic and therapeutic precision medicine market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 27 Germany diagnostic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 28 Germany therapeutic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 29 Germany precision medicine pharmaceuticals market estimates & forecasts, by indication area, 2014 - 2025 (USD Billion)
  • TABLE 30 Germany diagnostic and therapeutic precision medicine market estimates & forecasts, by end use, 2014 - 2025 (USD Billion)
  • TABLE 31 Asia Pacific diagnostic and therapeutic precision medicine market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 32 Asia Pacific diagnostic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 33 Asia Pacific therapeutic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 34 Asia Pacific precision medicine pharmaceuticals market estimates & forecasts, by indication area, 2014 - 2025 (USD Billion)
  • TABLE 35 Asia Pacific diagnostic and therapeutic precision medicine market estimates & forecasts, by end use, 2014 - 2025 (USD Billion)
  • TABLE 36 Japan diagnostic and therapeutic precision medicine market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 37 Japan diagnostic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 38 Japan therapeutic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 39 Japan precision medicine pharmaceuticals market estimates & forecasts, by indication area, 2014 - 2025 (USD Billion)
  • TABLE 40 Japan diagnostic and therapeutic precision medicine market estimates & forecasts, by end use, 2014 - 2025 (USD Billion)
  • TABLE 41 China diagnostic and therapeutic precision medicine market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 42 China diagnostic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 43 China therapeutic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 44 China precision medicine pharmaceuticals market estimates & forecasts, by indication area, 2014 - 2025 (USD Billion)
  • TABLE 45 China diagnostic and therapeutic precision medicine market estimates & forecasts, by end use, 2014 - 2025 (USD Billion)
  • TABLE 46 Latin America diagnostic and therapeutic precision medicine market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 47 Latin America diagnostic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 48 Latin America therapeutic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 49 Latin America precision medicine pharmaceuticals market estimates & forecasts, by indication area, 2014 - 2025 (USD Billion)
  • TABLE 50 Latin America diagnostic and therapeutic precision medicine market estimates & forecasts, by end use, 2014 - 2025 (USD Billion)
  • TABLE 51 Brazil diagnostic and therapeutic precision medicine market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 52 Brazil diagnostic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 53 Brazil therapeutic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 54 Brazil precision medicine pharmaceutical market estimates & forecasts, by indication area, 2014 - 2025 (USD Billion)
  • TABLE 55 Brazil diagnostic and therapeutic precision medicine market estimates & forecasts, by end use, 2014 - 2025 (USD Billion)
  • TABLE 56 MEA diagnostic and therapeutic precision medicine market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 57 MEA diagnostic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 58 MEA therapeutic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 59 MEA precision medicine pharmaceuticals market estimates & forecasts, by indication area, 2014 - 2025 (USD Billion)
  • TABLE 60 MEA diagnostic and therapeutic precision medicine market estimates & forecasts, by end use, 2014 - 2025 (USD Billion)
  • TABLE 61 South Africa diagnostic and therapeutic precision medicine market estimates & forecasts, by application, 2014 - 2025 (USD Billion)
  • TABLE 62 South Africa diagnostic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 63 South Africa therapeutic precision medicine market estimates & forecasts, by type, 2014 - 2025 (USD Billion)
  • TABLE 64 South Africa precision medicine pharmaceuticals market estimates & forecasts, by indication area, 2014 - 2025 (USD Billion)
  • TABLE 65 South Africa diagnostic and therapeutic precision medicine market estimates & forecasts, by end use, 2014 - 2025 (USD Billion)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain based sizing & forecasting
  • FIG. 6 QFD modelling for market share assessment
  • FIG. 7 Market summary
  • FIG. 8 Market trends & outlook
  • FIG. 9 Market segmentation & scope
  • FIG. 10 Market driver relevance analysis (Current & future impact)
  • FIG. 11 Market restraint relevance analysis (Current & future impact)
  • FIG. 12 SWOT analysis, by factor (Political & legal, economic and technological)
  • FIG. 13 Porter's five forces analysis
  • FIG. 14 Diagnostic and therapeutic precision medicine market by application outlook key takeaways
  • FIG. 15 Diagnostic and therapeutic precision medicine market: Application movement analysis
  • FIG. 16 Global diagnostics market 2014 - 2025 (USD Billion)
  • FIG. 17 Global genetic tests market 2014 - 2025 (USD Billion)
  • FIG. 18 Global direct to consumers market 2014 - 2025 (USD Billion)
  • FIG. 19 Global esoteric tests market 2014 - 2025 (USD Billion)
  • FIG. 20 Global other tests market 2014 - 2025 (USD Billion)
  • FIG. 21 Global therapeutics market 2014 - 2025 (USD Billion)
  • FIG. 22 Global pharmaceutical market 2014 - 2025 (USD Billion)
  • FIG. 23 Global oncology diseases market 2014 - 2025 (USD Billion)
  • FIG. 24 Global respiratory diseases 2014 - 2025 (USD Billion)
  • FIG. 25 Global skin diseases 2014 - 2025 (USD Billion)
  • FIG. 26 CNS diseases 2014 - 2025 (USD Billion)
  • FIG. 27 Global immunology diseases 2014 - 2025 (USD Billion)
  • FIG. 28 Global genetic disorders 2014 - 2025 (USD Billion)
  • FIG. 29 Global other diseases and disorders 2014 - 2025 (USD Billion)
  • FIG. 30 Global medical devices market 2014 - 2025 (USD Billion)
  • FIG. 31 Global others market 2014 - 2025 (USD Billion)
  • FIG. 32 Diagnostic and therapeutic precision medicine market end use outlook key takeaways
  • FIG. 33 Diagnostic and therapeutic precision medicine market: End use movement analysis
  • FIG. 34 Global home care market, 2014 - 2025 (USD Billion)
  • FIG. 35 Global hospitals market, 2014 - 2025 (USD Billion)
  • FIG. 36 Global clinical labs market, 2014 - 2025 (USD Billion)
  • FIG. 37 Global others market, 2014 - 2025 (USD Billion)
  • FIG. 38 Diagnostic and therapeutic precision medicine market place: By region key takeaway
  • FIG. 39 Diagnostic and therapeutic precision medicine regional outlook, 2017 & 2025
  • FIG. 40 North America diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
  • FIG. 41 U.S. diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
  • FIG. 42 Canada diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
  • FIG. 43 Europe diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
  • FIG. 44 U.K. diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
  • FIG. 45 Germany diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
  • FIG. 46 Asia Pacific diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
  • FIG. 47 Japan diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
  • FIG. 48 China diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
  • FIG. 49 Latin America diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
  • FIG. 50 Brazil diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
  • FIG. 51 MEA diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
  • FIG. 52 South Africa diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
  • FIG. 53 Strategy framework
  • FIG. 54 Participant categorization
目次
Product Code: GVR-2-68038-612-7

The global precision medicine (diagnostics/therapeutics) market size is expected to reach USD 85.5 billion by 2025 at a 9.9% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Trends such as introduction of cost-effective genomic and molecular biology testing methods, increasing prevalence of cancer and rare diseases, and rising use of big data in precision medicine are some of the key factors boosting market growth.

The Human Genome Project introduced some marvelous cutting-edge techniques such as whole genome sequencing and targeted sequencing. These technologies are being used by researchers for the study of genomes and creation of personalized therapies for treatment of various illnesses. Today, the prevalence of diseases in areas such as oncology, immunology, and neurology has rapidly increased across the globe.

Researchers, healthcare professionals, and big pharma and biotech companies are working together to recognize new focused treatments options for the wellbeing of patients. Currently, there are many therapies and drugs under clinical trials for treatment of different types of cancers. Moreover, researchers have also shown an inclination toward development of precision medicines and diagnostics in non-oncologic disease areas.

Apart from therapeutics, the diagnostics field has also witnessed rapid growth in the past few years. The use of next generation sequencing (NGS), biomarkers, companion diagnostics, and esoteric tests can possibly change and affect prescription patterns of pharmaceutical medicines. Personalized medicines have very high chances of becoming a massive success in the next 20 years and have the capacity to treat and cure a few obstinate illnesses, which was not possible before.

Involvement of government and regulatory bodies has played a very important role in the growth of this field. In 2015, the then U.S. government announced the launch of the Precision Medicine Initiative. The following year, China launched the China Precision Medicine Initiative, which is a 15-year project that aims to build the country as a leader in development of precision therapies.

At present, more than 40% of the medications in biotech and pharmaceutical companies' improvement pipeline incorporate biomarkers. The overview likewise recommended that some biopharmaceutical organizations have collaborated and joint their ventures in the past five years and are expected to continue doing so in the coming years. The diagnostic and therapeutic precision medicine market thus holds immense potential and is quickly turning into a fundamental segment of patient care.

Further key findings from the report suggest:

  • Technologies such as gene sequencing, biomarkers, big data analytics, and companion diagnostics are anticipated to drive this market in the coming years
  • By end use, clinical labs held the dominant share in the market in 2017. The home care testing segment, on the other hand, has been witnessing rapid growth due to its speed, efficiency, and convenience
  • On the basis of indication area, therapeutic precision medicines for oncology held the largest market share in 2017. However, there has been a change in focus of researchers toward the development of precision medicines for non-oncologic diseases. This has resulted in greater focus on immunological, genetic, and rare diseases
  • The North America market currently holds the largest share and is expected to grow further during the forecast period. The market is primarily driven by supportive policies and initiatives by the government and strong presence of market players. Asia Pacific is expected to emerge as the fastest growing region in this market
  • GE Healthcare; Abbott Laboratories; Precision Biologics; Foundation Medicine; Illumina, Inc.; and IBM Watson are some of the prominent players in the precision medicine diagnostics market and precision medicine therapeutics market

Table of Contents

Chapter 1: Research Methodology

  • 1.1 Information Procurement
  • 1.2 Information or Data Analysis
  • 1.3 Market Formulation & Validation
  • 1.4 List of Secondary Sources

Chapter 2: Executive Summary

  • 2.1 Market Summary

Chapter 3: Market Variables, Trends & Scope

  • 3.1 Market Segmentation, Trends & Scope
    • 3.1.1 Market driver analysis
      • 3.1.1.1 Drop in the prices of molecular testing and genetic sequencing
      • 3.1.1.2 Liquid biopsies emerging as the next big thing for detecting metastatic cancers
      • 3.1.1.3 Increasing demand for precision medicine and diagnostic precision medicines in non-oncology areas.
      • 3.1.1.4 Harnessing big data for improving preventive care
      • 3.1.1.5 Advancements in NGS, companion diagnostics and biomarkers
    • 3.1.2 Market restraint analysis
      • 3.1.2.1 Hefty price tags associated with precision medicine
      • 3.1.2.2 The cost associated with failure of clinical trials
      • 3.1.2.3 Presence of non-value-based PM diagnostics reimbursement policy
  • 3.2 Diagnostic and Therapeutic Precision Medicine Market - SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.3 Industry Analysis - Porter's

Chapter 4: Market Categorization: By Application

  • 4.1 Diagnostic And Therapeutic Precision Medicine Market: Application Movement Analysis
  • 4.2 Diagnostics
    • 4.2.1 Global diagnostics market 2014 - 2025 (USD Billion)
    • 4.2.2 Genetic tests
      • 4.2.2.1 Global genetic tests market 2014 - 2025 (USD Billion)
    • 4.2.3 Direct to consumer tests
      • 4.2.3.1 Global direct to consumers market 2014 - 2025 (USD Billion)
    • 4.2.4 Esoteric tests
      • 4.2.4.1 Global esoteric tests market 2014 - 2025 (USD Billion)
    • 4.2.5 Other tests
      • 4.2.5.1 Global other tests market 2014 - 2025 (USD Billion)
  • 4.3 Therapeutics
    • 4.3.1 Global therapeutics market 2014 - 2025 (USD Billion)
    • 4.3.2 Pharmaceuticals
      • 4.3.2.1 Global pharmaceuticals market 2014 - 2025 (USD Billion)
      • 4.3.2.2 Oncology
      • 4.3.2.2.1 Global oncology diseases market 2014 - 2025 (USD Billion)
      • 4.3.2.3 Respiratory diseases
      • 4.3.2.3.1 Global respiratory diseases 2014 - 2025 (USD Billion)
      • 4.3.2.4 Skin diseases
      • 4.3.2.4.1 Global skin diseases 2014 - 2025 (USD Billion)
      • 4.3.2.5 CNS diseases
      • 4.3.2.5.1 CNS diseases 2014 - 2025 (USD Billion)
      • 4.3.2.6 Immunology
      • 4.3.2.6.1 Global immunology diseases 2014 - 2025 (USD Billion)
      • 4.3.2.7 Genetic disorders
      • 4.3.2.7.1 Global genetic disorders 2014 - 2025 (USD Billion)
      • 4.3.2.8 Other diseases and disorders
      • 4.3.2.8.1 Global other diseases and disorders 2014 - 2025 (USD Billion)
    • 4.3.3 Medical devices
      • 4.3.3.1 Global medical devices market 2014 - 2025 (USD Billion)
    • 4.3.4 Others
      • 4.3.4.1 Global others market 2014 - 2025 (USD Billion)

Chapter 5: Market Categorization: Diagnostic And Therapeutic Precision Medicine Market By End Use

  • 5.1 Diagnostic And Therapeutic Precision Medicine Market: End Use Movement Analysis
  • 5.2 Home Care
    • 5.2.1 Global home care market, 2014 - 2025 (USD Billion)
  • 5.3 Hospitals
    • 5.3.1 Global hospitals market, 2014 - 2025 (USD Billion)
  • 5.4 Clinical Labs
    • 5.4.1 Global clinical labs market, 2014 - 2025 (USD Billion)
  • 5.5 Others
    • 5.5.1 Global others market, 2014 - 2025 (USD Billion)

Chapter 6: Market Categorization: Diagnostic And Therapeutic Precision Medicine Market By Region

  • 6.1 Global Diagnostic And Therapeutic Precision Medicine Market Share By Region, 2017 & 2025
  • 6.2 North America
    • 6.2.1 North America diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
    • 6.2.2 U.S.
      • 6.2.2.1 U.S. diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
    • 6.2.3 Canada
      • 6.2.3.1 Canada diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
  • 6.3 Europe
    • 6.3.1 Europe diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
    • 6.3.2 U.K.
      • 6.3.2.1 U.K. diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
    • 6.3.3 Germany
      • 6.3.3.1 Germany diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
    • 6.4.2 Japan
      • 6.4.2.1 Japan diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
    • 6.4.3 China
      • 6.4.3.1 China diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
  • 6.5 Latin America
    • 6.5.1 Latin America diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
    • 6.5.2 Brazil
      • 6.5.2.1 Brazil diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
  • 6.6 Middle East & Africa
    • 6.6.1 MEA diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)
    • 6.6.2 South Africa
      • 6.6.2.1 South Africa diagnostic and therapeutic precision medicine market, 2014 - 2025 (USD Billion)

Chapter 7: Competitive Landscape

  • 7.1 Strategy Framework
  • 7.2 Market Participation Categorization
  • 7.3 Company Profiles
    • 7.3.1 F. Hoffmann-La Roche Ltd.-Foundation Medicine
      • 7.3.1.1 Company overview
      • 7.3.1.1.1 Foundation Medicine
      • 7.3.1.2 Financial performance
      • 7.3.1.2.1 Financial Performance
      • 7.3.1.2.2 Product overview
      • 7.3.1.3 Growth strategies
    • 7.3.2 Siemens Healthineers
      • 7.3.2.1 Company overview
      • 7.3.2.2 Financial performance
      • 7.3.2.3 Product benchmarking
      • 7.3.2.4 Strategic initiatives
    • 7.3.3 Janssen Pharmaceuticals
      • 7.3.3.1 Company overview
      • 7.3.3.2 Financial performance
      • 7.3.3.3 Product overview
      • 7.3.3.4 Growth strategies
    • 7.3.4 Illumina
      • 7.3.4.1 Company overview
      • 7.3.4.2 Financial performance(thousands)
      • 7.3.4.3 Product overview
      • 7.3.4.4 Growth strategies
    • 7.3.5 Quest Diagnostics Incorporated.
      • 7.3.5.1 Company overview
      • 7.3.5.2 Financial performance
      • 7.3.5.3 Product benchmarking
      • 7.3.5.4 Strategic initiatives
    • 7.3.6 23andMe, Inc.
      • 7.3.6.1 Company overview
      • 7.3.6.2 Financial performance
      • 7.3.6.3 Product overview
    • 7.3.7 NeoDiagnostix, Inc.,
      • 7.3.7.1 Company overview
      • 7.3.7.2 Financial performance and highlights
      • 7.3.7.3 Product overview
    • 7.3.8 IBM Watson
      • 7.3.8.1 Financial performance
      • 7.3.8.2 Product overview
      • 7.3.8.3 Growth strategies
    • 7.3.9 Myriad Genetics Inc.
      • 7.3.9.1 Company overview
      • 7.3.9.2 Financial performance
      • 7.3.9.3 Product benchmarking
      • 7.3.9.4 Strategic initiatives
    • 7.3.10 Medtronic
      • 7.3.10.1 Company overview
      • 7.3.10.1.1 Covidien plc
      • 7.3.10.2 Financial performance
      • 7.3.10.3 Product benchmarking
      • 7.3.10.4 Strategic initiatives
    • 7.3.11 GE Healthcare
      • 7.3.11.1 Company overview
      • 7.3.11.2 Financial performance
      • 7.3.11.3 Product benchmarking
      • 7.3.11.4 Strategic initiatives
    • 7.3.12 Abbott Laboratories
      • 7.3.12.1 Company overview
      • 7.3.12.2 Financial performance
      • 7.3.12.3 Product benchmarking
      • 7.3.12.4 Strategic initiatives
    • 7.3.13 Dako A/S
      • 7.3.13.1 Company overview
      • 7.3.13.2 Financial performance
      • 7.3.13.3 Product benchmarking
      • 7.3.13.4 Strategic initiatives
    • 7.3.14 Biogen
      • 7.3.14.1 Company overview
      • 7.3.14.2 Financial performance
      • 7.3.14.3 Product benchmarking
      • 7.3.14.4 Strategic initiatives
    • 7.3.15 Precision Biologics Incorporated
      • 7.3.15.1 Company overview
      • 7.3.15.2 Financial performance
      • 7.3.15.3 Product benchmarking
      • 7.3.15.4 Strategic initiatives
    • 7.3.16 Qiagen Incorporated
      • 7.3.16.1 Company overview
      • 7.3.16.2 Financial performance
      • 7.3.16.3 Product benchmarking
      • 7.3.16.4 Strategic initiatives
Back to Top